ADCY2-CLPTM1L Fusion FISH Probe
The ADCY2-CLPTM1L Fusion FISH Probe is used to confirm a fusion of the ADCY2 and CLPTM1L genes. The fusion of the ADCY2 and CLPTM1L genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ADCY2-CLPTM1L-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ADCY2-CLPTM1L-20-AQAQ | 20 (40 μL) | 200 μL |
|
ADCY2 Gene Summary
This gene encodes a member of the family of adenylate cyclases, which are membrane-associated enzymes that catalyze the formation of the secondary messenger cyclic adenosine monophosphate (cAMP). This enzyme is insensitive to Ca(2+)/calmodulin, and is stimulated by the G protein beta and gamma subunit complex. [provided by RefSeq, Jul 2008]
Gene Name: Adenylate Cyclase 2
Chromosome: CHR5: 7396342 -7830194
Locus: 5p15.31
CLPTM1L Gene Summary
The protein encoded by this gene is a membrane protein whose overexpression in cisplatin-sensitive cells causes apoptosis. Polymorphisms in this gene have been reported to increase susceptibility to several cancers, including lung, pancreatic, and breast cancers. [provided by RefSeq, Nov 2015]
Gene Name: CLPTM1 Like
Chromosome: CHR5: 1317999 -1345002
Locus: 5p15.33
Gene Diseases
The ADCY2 CLPTM1L Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|